TearSolutions - About the company
TearSolutions is a series B company based in Charlottesville (United States), founded in 2013 by Mark Logan and Gordon Laurie. It operates as a Topical therapeutics for the treatment of dry eye disease. TearSolutions has raised $43M in funding. The company has 59 active competitors, including 17 funded and 12 that have exited. Its top competitors include companies like Lineage Cell Therapeutics, Remegen and Stellular Bio.
Company Details
TearSolutions develop topical therapeutics for the treatment of dry eye disease. Its lead product is a proprietary synthetic fragment of the protein lacritin. The company claims that Lacripep is equipotent with natural lacritin and can alleviate dry-eye symptoms for up to 16 hours. Its currently in phase I clinical trials.
- Website
- tearsolutions.com
- Email ID
- *****@tearsolutions.com
Key Metrics
Founded Year
2013
Location
Charlottesville, United States
Stage
Series B
Total Funding
$43M in 11 rounds
Latest Funding Round
Investors
Ranked
5th among 59 active competitors
Employee Count
10 as on Sep 30, 2026
Similar Companies
Sign up to download TearSolutions' company profile
TearSolutions's funding and investors
TearSolutions has raised a total funding of $43M over 11 rounds. Its first funding round was on Jun 25, 2014. TearSolutions has 7 institutional investors.
Here is the list of recent funding rounds of TearSolutions:
Filter this list
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Oct 29, 2025 | 6951288 | Series B | 4802586 | 6282393 | 9568298 | 7236964 |
Sep 25, 2024 | 1992196 | Series B | 5571340 | 9062059 | 8909836 | 2097307 |
Sep 08, 2023 | 7401201 | Series B | 5311524 | 6996704 | 6377233 | 9313345 |
View details of TearSolutions's funding rounds and investors
TearSolutions' founders and board of directors
Founder? Claim ProfileThe founders of TearSolutions are Mark Logan and Gordon Laurie.
Here are the details of TearSolutions' key team members:
- Mark Logan: Co-Founder & CEO of TearSolutions. They are also an angel investor in 1 startup and serve on the board of 1 company.Contact Info: 1 email address
- Gordon Laurie: Co-Founder of TearSolutions. Contact Info: 1 email address
View details of TearSolutions's Founder profiles and Board Members
TearSolutions' employee count trend
TearSolutions has 10 employees as of Sep 26. Here is TearSolutions's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
TearSolutions's Competitors and alternates
Top competitors of TearSolutions include Lineage Cell Therapeutics, Remegen and Stellular Bio. Here is the list of Top 10 competitors of TearSolutions, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Lineage Cell Therapeutics 1990, Carlsbad (United States), Public | Developer of cell based therapies for the treatment of cancer, eye disease and spinal disorders | $23M | 65/100 | |
2nd | Developer of therapies for the treatment of cancer, autoimmune and eye diseases | $100M | 62/100 | ||
3rd | Stellular Bio 2014, Watertown (United States), Series A | Developer of a platform for producing allogeneic, stem-cell-derived platelet-like cells | $37.5M | 59/100 | |
4th | Valitor 2010, Berkeley (United States), Series B | Developer of therapeutic proteins for multiple disease conditions | $38.2M | 56/100 | |
5th | TearSolutions 2013, Charlottesville (United States), Series B | Topical therapeutics for the treatment of dry eye disease | $43M | 54/100 | |
6th | Retrotope 2006, Los Altos (United States), Acquired | Developer of therapeutics to treat neurodegenerative and ophthalmological diseases | $69.6M | 53/100 | |
7th | Stuart Therapeutics 2017, Stuart (United States), Series A | Developer of therapies for treating ophthalmic, gastrointestinal, inflammatory disorders | $11M | 53/100 | |
8th | Developer of drugs for neuromuscular and age-related diseases | $2.6M | 52/100 | ||
9th | OKYO Pharma 2018, London (United Kingdom), Public | Developer of therapeutics for the treatment of dry eye disease and chronic pain management | - | - | 52/100 |
10th | Azura Ophthalmics 1997, Tel Aviv (Israel), Series C | Developing therapies for meibomian gland dysfunction | $37.2M | 50/100 |
Looking for more details on TearSolutions's competitors? Click here to see the top ones
TearSolutions's Investments and acquisitions
TearSolutions has made no investments or acquisitions yet.
Reports related to TearSolutions
Here is the latest report on TearSolutions's sector:
News related to TearSolutions
Media has covered TearSolutions for 1 event in last 1 year.
•
•
•
Tearsolutions, Inc. Appoints Louis M Alpern, Md, Mph, Facs, Fics To Its Board Of DirectorsBenzinga•Apr 03, 2024•TearSolutions
•
TearSolutions Expands and Establishes Advisory Boards and Strengthens Leadership TeamGlobeNewswire•Mar 06, 2023•TearSolutions
•
TearSolutions Announces Results From Primary Sjögren’s Syndrome Trial and Appoints Anil Asrani President and CEOEyewire News•Oct 05, 2020•TearSolutions, Medtronic
•
TearSolutions Completes Closing of $6.4 Million Financing RoundVision Monday•Apr 12, 2019•TearSolutions, VTC Innovation Fund, University of Virginia
•
Charlottesville Startup Gets $8.5 Million Via Tech/Carilion Venture Group, Russian CompanyCitybizlist•Dec 08, 2017•TearSolutions, VTC Innovation Fund
•
TearSolutions Raises $3M Series A Round to Advance the Treatment of Dry EyeUniversity of Virginia•Nov 09, 2015•TearSolutions, Santen Pharmaceuticals, LaunchCapital, Center for Innovative Technology
•
Are you a Founder ?
FAQs about TearSolutions
Explore our recently published companies
- Inovant Solutions - India based, 2011 founded, Unfunded company
- Infinity StoneX - Visakhapatnam based, Unfunded company
- Southwest Custom Build - Albuquerque based, 2008 founded, Unfunded company
- Grow&Bless Digital - Jakarta based, 2020 founded, Unfunded company
- Eshwar Venugopal - 2013 founded, Unfunded company
- KIWI Agency - Miami based, 2017 founded, Unfunded company